Shape mediated splenotropic delivery of buparvaquone loaded solid lipid nanoparticles
- 61 Downloads
Buparvaquone (BPQ)–loaded asymmetric solid lipid nanoparticles (SLN) prepared by a modified nanoprecipitation method were evaluated for splenotropic drug delivery. BPQ SLN exhibited an average particle size of 650.28 ± 6.75 nm with polydispersity index ≤ 0.3, entrapment efficiency of 96.57 ± 0.190%, and drug loading of 24.63 ± 0.042%. Scanning electron microscopy (SEM) revealed elongated particles with flattened and rounded edges. Aspect ratio, an important determinant of asymmetricity of the BPQ SLN, measured as the ratio of average length (1143 ± 0.083 nm) to width (419 ± 0.031 nm) was found to be 2.727 ± 0.19. The hemolytic potential of 10.86 ± 0.04% and good serum stability suggested feasibility for intravenous administration. 99mTc-labeled BPQ SLN revealed high radiolabeling efficiency (> 95%) and good stability. Intravenous administration in mice revealed > 75% accumulation in the reticuloendothelial system organs. The percent radioactivity per gram of organ was in the order spleen > kidney > lungs > liver > lymph nodes, with high splenic accumulation and significantly lower concentration in the liver. An astoundingly high spleen/liver ratio with a maximum of 11.94 ± 1.37 at 3 h, which confirmed high splenic uptake is attributed to Kupffer cell bypass. Other factors contributing to splenotropy are the rigidity and the low molecular weight of the lipid in the BPQ SLN which enabled translocation of the particles into the splenic pulp. Our study proposes asymmetric BPQ SLN as a promising splenotropic delivery system for improved efficacy in theileriosis, a spleen resident infection.
KeywordsSolid lipid nanoparticles Splenotropy Gamma scintigraphy Asymmetric shape Splenic uptake Buparvaquone
Heena V. Maithania is thankful to University Grants Commission- Special Assistance Program (UGC-SAP) for providing senior research fellowship and Sotax India Pvt. Ltd. for USP apparatus IV.
Compliance with ethical standards
The manuscript entitled “Shape mediated splenotropic delivery of buparvaquone loaded solid lipid nanoparticles” complies with the current laws of India.
Conflict of interest
The authors declare that they have no conflict of interest.
- 2.Shkap V, Leibovich B, Krigel Y, Lea F, Orgad U. Evaluation of the combined formulation of parvaquone and frusemide (Fruvexon) in the treatment of experimental tropical theileriosis. Intern J Appl Res Vet Med. 2010;8(1):73–7.Google Scholar
- 5.Preston PM, Jackson LA, Sutherland IA, Brown DJ, Schofield J, Bird T, et al. Theileria annulata: attenuation of a Schizont-infected cell line by prolonged in vitro culture is not caused by the preferential growth of particular host cell types. Exp Parasitol. 2001;98:188–205.CrossRefPubMedGoogle Scholar
- 13.Harris BJ, Dalhaimer P. Particle shape effects in vitro and in vivo. Front Biosci. 2012;1(4):1344–53.Google Scholar
- 26.Lee SY, Ferrari M, Decuzzi P. Shaping nano/microparticles for enhanced vascular interaction in laminar flows. Nanotechnology. 2009;20:1–11.Google Scholar
- 29.Klibanov AL, Maruyama K, Beckerleg AM, Torchilin VP, Huang L. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim Biophys Acta. 1991;1062:142–8.CrossRefPubMedGoogle Scholar
- 43.Garg M, Garg BR, Jain S, Mishra P, Sharma RK, Mishra AK, et al. Radiolabeling, pharmacoscintigraphic evaluation and antiretroviral efficacy of stavudine loaded 99mTc labeled galactosylated liposomes. Eur J Pharm Biopharm. 2008;33(3):271–81.Google Scholar
- 46.Krzyzaniak JF, Yalkowsky SH. Lysis of human red blood cells. Effect of contact time on surfactant-induced hemolysis. J Pharm Sci and Technol. 1998;52:66–9.Google Scholar
- 49.Atkins H, Richards P. Assessment of thyroid function and anatomy with technetium -99m as pertechnetate. J Nucl Med. 1967;9(1):1–10.Google Scholar
- 51.Patel MD, Date PV, Gaikwad RV, Samad A, Malshe VC, Devarajan PV. Comparative evaluation of polymeric nanoparticles of rifampicin comprising Gantrez and poly(ethylene sebacate) on pharmacokinetics, biodistribution and lung uptake following oral administration. J Biomed Nanotechnol. 2013;9:1–8.CrossRefGoogle Scholar
- 53.D’Souza AA, Jain P, Galdhar CN, Samad A, Degani MS, Devarajan PV. Comparative in silico-in vivo evaluation of ASGP-R ligands for hepatic targeting of curcumin Gantrez nanoparticles. AAPS J 2013; 1–11.Google Scholar
- 56.Nolte MA, Beliën JAM, Schadee-Eestermans I, Jansen W, Unger WWJ, van Rooijen N, Kraal G, Mebius RE. A conduit system distributes chemokines and small blood-borne molecules through the splenic white pulp. J Exp Med 2015, 505–512.Google Scholar